Literature DB >> 7000692

Immunological cross-reactivity of heat-labile enterotoxins produced by enterotoxigenic and enteropathogenic strains of Escherichia coli.

F A Klipstein, R F Engert, H B Short.   

Abstract

Weanling rats were immunized with a heat-labile enterotoxin contained in whole cell lysate (WCL) ultrafiltrate preparations of enteropathogenic (EPEC) and enterotoxigenic (ETEC) strains or with a purified preparation of heat-labile toxin (LT) from the ETEC strain and then challenged either with viable bacteria of each strain or the purified ETEC LT by means of the ileal ligated loop technique. Immunization with the WCL toxin preparations of either the EPEC or ETEC strain conferred protection against challenge with viable organisms of both strains; immunization with a similar preparation from a nontoxigenic strain did not yield protection. Immunization with either the WCL or purified LT toxin from ETEC strain afforded protection against challenge with the ETEC LT toxin, but immunization with the EPEC WCL preparation did not. The antigenicity of all of the toxin preparations was destroyed by heat-treatment. Possible contributory protective effects of somatic or colonization factor (CFA) antigens present in the WCL were excluded by the findings that protection was afforded against a heterologous somatic serotype, ileal bacterial counts were not reduced in protected animals, and WCL preparations of strains containing or lacking CFA yielded equal protection. These observations indicate that the heat-labile enterotoxin of EPEC strains is antigenic and is immunologically related to a heat-labile toxin present in similarly prepared material from an ETEC strain but not to the conventional LT toxin of ETEC strains. They suggest that the WCL preparation of the ETEC strain contains two heat-labile enterotoxins, one of which is conventional LT and the other of which resembles the EPEC toxin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000692      PMCID: PMC1458238     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Relation of rabbit gut reaction to enteropathogenic Escherichia coli.

Authors:  J TAYLOR; M P WILKINS; J M PAYNE
Journal:  Br J Exp Pathol       Date:  1961-02

2.  A study of the pathogenicity of strains of Bacterium coli from acute and chronic enteritis.

Authors:  S N DE; K BHATTACHARYA; J K SARKAR
Journal:  J Pathol Bacteriol       Date:  1956-01

3.  Pathogenesis of Escherichia coli enteritis in the ligated rabbit gut.

Authors:  M M Drucker; R Yeivin; T G Sacks
Journal:  Isr J Med Sci       Date:  1967 May-Jun

4.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

5.  Enteropathogenic Escherichia coli: lack of correlation of serotype with pathogenicity.

Authors:  M C Goldschmidt; H L DuPont
Journal:  J Infect Dis       Date:  1976-02       Impact factor: 5.226

6.  Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

7.  Enterotoxin testing of Escherichia coli causing epidemic infantile enteritis in the U.K.

Authors:  R J Gross; S M Scotland; B Rowe
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

8.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli.

Authors:  R B Sack; J L Froehlich
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

10.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.